辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PFE 辉瑞

盘前交易 01-14 08:47:51 EST

25.15

-0.12

-0.47%

盘前25.19

+0.04+0.16%

08:47 EST

最高25.39	最低24.97	成交量4,766万
今开25.32	昨收25.27	日振幅1.64%
总市值1,430亿	流通市值1,427亿	总股本56.86亿
成交额11.97亿	换手率0.84%	流通股本56.76亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"辉瑞","latestPrice":25.15,"timestamp":1768338000000,"preClose":25.27,"halted":0,"volume":47656033,"hourTrading":{"tag":"盘前","latestPrice":25.189,"preClose":25.15,"latestTime":"08:47 EST","volume":3479678,"amount":87520269.51074,"timestamp":1768398463475},"delay":0,"floatShares":5675908374,"shares":5685707552,"eps":1.726245,"marketStatus":"盘前交易","change":-0.12,"latestTime":"01-14 08:47:51 EST","open":25.32,"high":25.39,"low":24.9746,"amount":1196501116.619759,"amplitude":0.016438,"askPrice":25.19,"askSize":70,"bidPrice":25.18,"bidSize":2031,"shortable":3,"etf":0,"ttmEps":1.726245,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768401000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":25.15,"dividendRate":0.067594,"preHourTrading":{"tag":"盘前","latestPrice":25.189,"preClose":25.15,"latestTime":"08:47 EST","volume":3479678,"amount":87520269.51074,"timestamp":1768398463475},"postHourTrading":{"tag":"盘后","latestPrice":25.13,"preClose":25.15,"latestTime":"19:59 EST","volume":5132764,"amount":129083767.5089,"timestamp":1768352385221},"volumeRatio":1.0369182155033865,"optionData":{"bulkOrders":[{"symbol":"PFE","call":false,"expireDate":1771563600000,"strike":"23.0","timestamp":1768315849853,"price":0.18,"volume":32000,"amount":576000,"type":"+"},{"symbol":"PFE","call":true,"expireDate":1773979200000,"strike":"28.0","timestamp":1768322315016,"price":0.18,"volume":2000,"amount":36000,"type":"+"}]},"impliedVol":0.26,"impliedVolPercentile":0.216},"requestUrl":"/m/hq/s/PFE","defaultTab":"news","newsList":[{"id":"2603630560","title":"辉瑞首席执行官称公司正推动获得FDA优先审评券","url":"https://stock-news.laohu8.com/highlight/detail?id=2603630560","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603630560?lang=zh_cn&edition=full","pubTime":"2026-01-14 04:36","pubTimestamp":1768336560,"startTime":"0","endTime":"0","summary":"辉瑞（Pfizer，PFE）周二尾盘下跌0.7%，此前该公司CEO称公司正推动获得FDA优先审评券。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-14/doc-inhhffax6925009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","IE00B19Z3581.USD","SG9999002232.USD","LU1066053197.SGD","LU1057294990.SGD","LU0321505439.SGD","LU1066051498.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU0225771236.USD","IE00BLSP4452.SGD","LU0306806265.USD","SG9999003800.SGD","BK4588","SG9999013999.USD","LU0225284248.USD","BK4534","LU0306807586.USD","LU0456855351.SGD","BK4599","IE00B19Z3B42.SGD","BK4007","LU0985481810.HKD","LU1894683264.USD","BK4550","BK4568","LU0234572021.USD","BK4533","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU0321505868.SGD","SG9999011175.SGD","SG9999001176.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1894683348.USD","SG9999001176.SGD","PFE","BK4585","LU0122379950.USD","SG9999002224.SGD","LU1023059063.AUD","SGXZ57979304.SGD","BK4592","LU0170899867.USD"],"gpt_icon":0},{"id":"2603691636","title":"FDA概述细胞/基因疗法CMC灵活性 可能对诺华与辉瑞有利","url":"https://stock-news.laohu8.com/highlight/detail?id=2603691636","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603691636?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:01","pubTimestamp":1768320060,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）详细说明了为加速细胞与基因治疗开发而定制的生产与控制让步措施，同时保持标准，这可能对诺华（NVS）和辉瑞（PFE）等开发商构成潜在利好。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-14/doc-inhheupf5646437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B19Z3581.USD","LU1066053197.SGD","LU0234572021.USD","LU1023059063.AUD","IE00B2B36J28.USD","IE00BBT3K403.USD","SG9999002232.USD","LU1363072403.SGD","LU0170899867.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","BK4592","SG9999001176.USD","BK4585","LU0306807586.USD","BK4533","IE00BFXG1179.USD","LU0211331839.USD","NVS","IE00B1BXHZ80.USD","SG9999002224.SGD","BK4550","IE00BLSP4452.SGD","SG9999003800.SGD","LU0868494617.USD","BK4568","LU0320765489.SGD","BK4006","LU0882574139.USD","LU1057294990.SGD","LU2237443895.HKD","SG9999013999.USD","LU0456855351.SGD","IE00BLSP4239.USD","LU1894683348.USD","LU2237443465.HKD","LU2237443382.USD","IE0002141913.USD","BK4588","IE00BHPRN162.USD","PFE","IE000M9KFDE8.USD","BK4532","LU0267386448.USD","LU2237443622.USD","IE0002270589.USD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU0306806265.USD","LU2746668974.SGD","IE0009355771.USD","LU0971096721.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU0321505439.SGD","BK4007","LU0208291251.USD","LU2237443978.SGD","LU1894683264.USD","BK4599","BK4578","BK4534","LU1066051498.USD","LU0321505868.SGD","LU0149725797.USD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU2237443549.SGD","LU0122379950.USD","LU1883839398.USD","BK4581","LU2746668461.USD","LU0985481810.HKD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU0225771236.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","LU0070302665.USD"],"gpt_icon":0},{"id":"1162317285","title":"辉瑞CEO预计2028年推出通过收购Metsera获得的下一代减肥资产","url":"https://stock-news.laohu8.com/highlight/detail?id=1162317285","media":"美股速递","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162317285?lang=zh_cn&edition=full","pubTime":"2026-01-13 02:17","pubTimestamp":1768241846,"startTime":"0","endTime":"0","summary":"辉瑞首席执行官在摩根大通会议上透露，公司计划于2028年正式推出通过收购Metsera获得的下一代减肥治疗资产。这一战略布局标志着辉瑞正式进军前景广阔的减肥药物市场。\n此次收购将使辉瑞获得Metsera在代谢疾病领域的前沿研发成果。新一代减肥资产预计将采用创新技术路径，与现有疗法形成差异化竞争。该时间表显示辉瑞正加速推进相关产品的临床开发进程。\n全球减肥药物市场规模预计将在未来五年内突破千亿美元。辉瑞此次布局不仅完善了其代谢疾病产品管线，更有望在诺和诺德、礼来等企业主导的市场中开辟新的增长空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0306806265.USD","LU0321505868.SGD","LU0456855351.SGD","LU1883839398.USD","LU1023059063.AUD","SGXZ57979304.SGD","LU0234572021.USD","BK4007","BK4550","IE00BLSP4239.USD","LU0122379950.USD","LU0321505439.SGD","PFE","LU1894683348.USD","SG9999011175.SGD","LU1057294990.SGD","SG9999013999.USD","IE00BLSP4452.SGD","IE0002270589.USD","LU1066051498.USD","LU0985481810.HKD","IE00BBT3K403.USD","BK4585","BK4533","IE00B19Z3B42.SGD","LU0225771236.USD","LU0289739699.SGD","LU0058720904.USD","BK4588","LU0306807586.USD","LU0225284248.USD","BK4581","SG9999003800.SGD","SG9999001176.SGD","BK4592","LU0170899867.USD","LU1894683264.USD","SG9999002232.USD","BK4599","IE000M9KFDE8.USD","LU1066053197.SGD","SG9999002224.SGD","BK4568","SG9999001176.USD","BK4534","LU0868494617.USD"],"gpt_icon":0},{"id":"2602553921","title":"BioNTech、辉瑞大举进攻，PD-(L)1/VEGF双抗开始分化了","url":"https://stock-news.laohu8.com/highlight/detail?id=2602553921","media":"氨基观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602553921?lang=zh_cn&edition=full","pubTime":"2026-01-11 13:39","pubTimestamp":1768109940,"startTime":"0","endTime":"0","summary":"文｜氨基观察1月6日，美国Instil Bio宣布，其子公司Axion Bio决定终止与宜明昂科此前达成的合作协议，涉及PD-L1/VEGF双抗AXN-2510以及CTLA-4单抗AXN-27M。消息公布当日，Instil Bio股价暴跌53%，回落至交易前水平。尤其是随着PD-1+ADC的疗效被反复验证后，PD-1/VEGF双抗的联用正迅速铺开。/ 03 /分化开始AXN-2510的“退货”开启了PD-1/VEGF赛道的分化。截至目前，全球范围内PD-1/VEGF双抗的项目已超过40个，其中国内就有20余款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260111134716a70cd852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260111134716a70cd852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0210528500.USD","LU0289739699.SGD","LU0122379950.USD","LU0306806265.USD","LU0985481810.HKD","LU0225771236.USD","BNTX","LU0321505868.SGD","BK4007","BK4585","SG9999013999.USD","BK4592","SG9999002232.USD","LU0053666078.USD","LU2487616109.SGD","LU0456855351.SGD","BK4588","PFE","BK4550","LU1066051498.USD","LU1023059063.AUD","SG9999002224.SGD","IE00BBT3K403.USD","LU0868494617.USD","BK4568","IE00B19Z3B42.SGD","SGXZ57979304.SGD","BK4107","LU1169589451.USD","BK4534","LU0321505439.SGD","LU0306807586.USD","SG9999001176.USD","LU0058720904.USD","LU1883839398.USD","LU1894683348.USD","SG9999011175.SGD","IE0002270589.USD","LU1894683264.USD","BK4533","IE00B19Z3581.USD","LU1057294990.SGD","SG9999001176.SGD","LU1169590202.USD","SG9999003800.SGD","IE00BLSP4239.USD","LU0234572021.USD","IE000M9KFDE8.USD","BK4023","LU0170899867.USD","LU1066053197.SGD","BK4581","IE00BLSP4452.SGD","BK4599","LU0225284248.USD"],"gpt_icon":1},{"id":"2602753981","title":"复星，收到辉瑞打款10亿元！","url":"https://stock-news.laohu8.com/highlight/detail?id=2602753981","media":"IVD资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602753981?lang=zh_cn&edition=full","pubTime":"2026-01-10 19:41","pubTimestamp":1768045308,"startTime":"0","endTime":"0","summary":"IVD资讯综合复星公告据药圈观察局报道，复星医药旗下药友制药已收到辉瑞支付的首付款15000万美元 。YP05002 为本集团自主研发并拥有自主知识产权的口服小分子胰高血糖素样肽-1 受体激动剂；其主要通过激活人的 GLP-1R，促进胰腺的胰岛素分泌和降低胰高血糖素分泌，在胃肠道抑制胃排空和肠道的蠕动,并通过影响中枢抑制食欲减少能量的摄入等机制，用于治疗 2 型糖尿病、肥胖症及其相关疾病。截至本公告日期，YP05002 于澳大利亚处于I期临床试验阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110195426a4b3c6b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110195426a4b3c6b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE","02196","BK1515","BK1593","BK1191"],"gpt_icon":1},{"id":"2602379717","title":"不再迷惘的制药商：2025年并购额暴涨124%，巨头狂扫创新药资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2602379717","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602379717?lang=zh_cn&edition=full","pubTime":"2026-01-09 21:50","pubTimestamp":1767966634,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，下周，制药商们将赴旧金山出席摩根大通医疗健康年会，心态较2025年显著放松。多起交易消息公布后，买方股价应声上涨，表明投资者希望它们继续出手。部分交易人士预计，2026年还将好于去年。数据显示，2025年制药商共达成1300亿美元交易，较上年增长124%。在FDA政策走向彻底明朗前，业内普遍预期部分制药商将对重大并购交易采取更为审慎的态度。","market":"sh","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391216.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BMY","MRK","PFE"],"gpt_icon":0},{"id":"2602006340","title":"千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","url":"https://stock-news.laohu8.com/highlight/detail?id=2602006340","media":"智通财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602006340?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:00","pubTimestamp":1767945631,"startTime":"0","endTime":"0","summary":"而多种因素共同促成了生物科技并购的爆发式增长。一些全球最畅销的药物正面临在关键地区失去专利保护的风险，这被业内称为“专利悬崖”。据计算，到2032年，畅销品牌专利保护期的丧失将造成至少1739亿美元的年销售额损失。生物科技板块近几年经历繁荣、衰退，然后又是繁荣新冠疫情期间，生物科技行业迅速成为投资者的热门之选。Loren表示，一系列利好数据也推高了生物科技股的估值。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390856.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRK","NVS","PFE","LLY","NVO","AZN","GSK","BMY"],"gpt_icon":1},{"id":"1158104265","title":"辉瑞将保留通过Boltz模型与平台支持发现或开发所有化合物的完整所有权","url":"https://stock-news.laohu8.com/highlight/detail?id=1158104265","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158104265?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:58","pubTimestamp":1767880735,"startTime":"0","endTime":"0","summary":"辉瑞宣布，公司将完全保留所有借助Boltz模型及平台支持所发现或开发化合物的所有权。这一决定进一步巩固了辉瑞在药物研发领域对核心知识产权的控制力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU1057294990.SGD","BK4599","LU1066053197.SGD","SG9999003800.SGD","LU1894683348.USD","SG9999001176.USD","LU0321505439.SGD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU0868494617.USD","LU0985481810.HKD","LU0321505868.SGD","BK4534","BK4533","LU0456855351.SGD","BK4592","IE00BLSP4452.SGD","LU0225771236.USD","BK4585","BK4550","BK4588","PFE","SG9999002232.USD","LU1023059063.AUD","LU0306807586.USD","SGXZ57979304.SGD","LU0058720904.USD","LU0306806265.USD","BK4007","LU0289739699.SGD","SG9999001176.SGD","SG9999011175.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","LU0225284248.USD","BK4568","LU0122379950.USD","SG9999013999.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU0234572021.USD","LU1066051498.USD","LU1894683264.USD","IE0002270589.USD","IE00B19Z3581.USD","BK4581"],"gpt_icon":0},{"id":"2601933943","title":"药友制药：已收到辉瑞支付的1.5亿美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2601933943","media":"新浪财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601933943?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:04","pubTimestamp":1767855840,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，请问辉瑞的1.5亿美元首付款是否已经打款给药友制药了？董秘回答：2025年12月9日，本公司参股子公司药友制药与上海复星医药产业发展有限公司及辉瑞共同签订《Collaboration and License Agreement》，其中主要包括由药友制药就口服小分子胰高血糖素样肽-1受体激动剂及含有该活性成分的产品授予辉瑞于许可区域及领域独家开发、使用、生产及商业化权利。截止目前，药友制药已收到辉瑞支付的首付款15,000万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164510a4ab4314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164510a4ab4314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","SG9999002224.SGD","LU0321505868.SGD","LU0225771236.USD","LU0234572021.USD","SG9999003800.SGD","IE0002270589.USD","LU0170899867.USD","BK4599","LU0122379950.USD","LU0289739699.SGD","LU0456855351.SGD","BK4550","LU1066053197.SGD","BK4585","SG9999011175.SGD","LU0321505439.SGD","BK4007","LU0306806265.USD","LU1057294990.SGD","SG9999001176.USD","LU0225284248.USD","SG9999002232.USD","BK4581","BK4588","LU1894683264.USD","IE000M9KFDE8.USD","PFE","SG9999001176.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","IE00BLSP4239.USD","BK4534","SG9999013999.USD","LU1883839398.USD","LU0985481810.HKD","LU0868494617.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU1023059063.AUD","LU1066051498.USD","BK4533","LU0306807586.USD","IE00BLSP4452.SGD","LU0058720904.USD","IE00B19Z3581.USD","BK4592"],"gpt_icon":0},{"id":"2600034413","title":"2026年美国超350种药品将涨价","url":"https://stock-news.laohu8.com/highlight/detail?id=2600034413","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600034413?lang=zh_cn&edition=full","pubTime":"2026-01-01 11:19","pubTimestamp":1767237540,"startTime":"0","endTime":"0","summary":"据医疗保健研究公司数据，2026年美国预计超350种药品价格将上涨，包括多种疫苗及部分癌症治疗药物等，数量较去年同期增加，涨价幅度与去年基本持平，降价药物不到十种。涉及涨价的制药商包括辉瑞、赛诺菲等，其中辉瑞涨价幅度最大，涉及约80种药品，大部分涨价幅度低于10%，但新冠疫苗涨价约15%，部分医院常用药涨幅超四倍。辉瑞称小幅涨价是为支持投资、继续投入新药研发并应对成本上涨。此外，葛兰素史克计划将约20种药品和疫苗价格上调2%至8.9%，称涨价是为支持科学创新、维持合理价格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101112617a6e7a59c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101112617a6e7a59c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234572021.USD","LU0289739699.SGD","IE00B19Z3581.USD","BK4585","LU0122379950.USD","LU0225771236.USD","LU0321505439.SGD","IE0002270589.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU1894683348.USD","SG9999001176.SGD","SG9999011175.SGD","BK4534","LU0170899867.USD","BK4588","IE00BLSP4239.USD","SG9999002224.SGD","IE00BBT3K403.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU1057294990.SGD","BK4599","SG9999013999.USD","LU0058720904.USD","BK4581","BK4568","BK4550","LU1023059063.AUD","SG9999001176.USD","BK4007","LU0306806265.USD","BK4533","LU1894683264.USD","LU1883839398.USD","LU1066053197.SGD","LU0456855351.SGD","SG9999002232.USD","LU0225284248.USD","BK4592","PFE","LU0306807586.USD","LU0321505868.SGD","SG9999003800.SGD","SGXZ57979304.SGD","LU0868494617.USD"],"gpt_icon":0},{"id":"2595774078","title":"美国食品药品监督管理局(FDA)宣布撤销授予辉瑞公司的辉瑞旗下Lucira新冠与流感家用检测产品的紧急使用授权。","url":"https://stock-news.laohu8.com/highlight/detail?id=2595774078","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595774078?lang=zh_cn&edition=full","pubTime":"2025-12-31 21:52","pubTimestamp":1767189156,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SG9999001176.SGD","LU0170899867.USD","BK4533","LU1066053197.SGD","LU0321505439.SGD","PFE","IE00BLSP4239.USD","LU0306806265.USD","SG9999002224.SGD","SG9999011175.SGD","LU0868494617.USD","BK4585","BK4592","IE00BBT3K403.USD","LU0985481810.HKD","LU1023059063.AUD","BK4550","IE00B19Z3581.USD","SG9999002232.USD","SG9999013999.USD","LU0234572021.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU0058720904.USD","LU0225284248.USD","LU0122379950.USD","SG9999003800.SGD","IE0002270589.USD","BK4568","LU0306807586.USD","SGXZ57979304.SGD","BK4599","LU0225771236.USD","BK4007","LU0321505868.SGD","LU1066051498.USD","BK4581","LU0456855351.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU1883839398.USD","IE00BLSP4452.SGD","BK4534","BK4588","LU1894683348.USD","LU1894683264.USD","SG9999001176.USD"],"gpt_icon":0},{"id":"1143354977","title":"联邦公报网站：FDA宣布撤销对辉瑞Lucira新冠与流感家用检测试剂的紧急使用授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1143354977","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143354977?lang=zh_cn&edition=full","pubTime":"2025-12-31 21:51","pubTimestamp":1767189117,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）近日通过联邦公报网站发布公告，正式撤销此前授予辉瑞公司旗下Lucira品牌新冠与流感家用检测试剂组合产品的紧急使用授权。\n该决定标志着这款曾获紧急批准的家用检测产品将退出市场。公告未具体说明撤销授权的详细原因，但此类行动通常基于产品性能、市场需求或制造商主动申请等因素。\n此次授权撤销仅涉及特定检测产品，不影响辉瑞其他已获授权的医疗产品。FDA建议消费者关注其官网更新的合格检测产品清单，确保使用经批准的检测工具。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","LU1066053197.SGD","LU0234572021.USD","LU1023059063.AUD","LU0306807586.USD","LU0122379950.USD","BK4585","SG9999002232.USD","BK4007","PFE","LU0321505439.SGD","LU1057294990.SGD","BK4550","LU0868494617.USD","SG9999001176.USD","BK4599","LU0225284248.USD","LU0170899867.USD","LU0321505868.SGD","IE0002270589.USD","BK4533","BK4592","LU0058720904.USD","BK4534","SG9999013999.USD","LU1066051498.USD","LU1894683348.USD","IE000M9KFDE8.USD","LU0225771236.USD","BK4581","IE00B19Z3581.USD","SG9999011175.SGD","LU1883839398.USD","SG9999002224.SGD","SG9999003800.SGD","SGXZ57979304.SGD","BK4568","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU0456855351.SGD","LU0985481810.HKD","BK4588","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU0289739699.SGD","SG9999001176.SGD","LU1894683264.USD"],"gpt_icon":0},{"id":"1158002555","title":"辉瑞收到1270万卢比的税务索赔通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1158002555","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158002555?lang=zh_cn&edition=full","pubTime":"2025-12-24 21:09","pubTimestamp":1766581749,"startTime":"0","endTime":"0","summary":"12月24日 - 辉瑞有限公司收到一份价值1270万卢比的税务索赔通知。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4533","LU1894683264.USD","LU0868494617.USD","SG9999002224.SGD","IE00BLSP4452.SGD","BK4588","BK4534","IE0002270589.USD","IE00BLSP4239.USD","LU1023059063.AUD","IE00B19Z3581.USD","LU0289739699.SGD","LU0234572021.USD","SG9999001176.USD","SG9999002232.USD","LU0985481810.HKD","LU0306807586.USD","IE00B19Z3B42.SGD","BK4568","BK4599","LU1066051498.USD","LU1894683348.USD","LU0170899867.USD","BK4550","LU0306806265.USD","BK4592","LU0321505868.SGD","LU1883839398.USD","SG9999011175.SGD","SGXZ57979304.SGD","SG9999001176.SGD","LU1066053197.SGD","LU0225771236.USD","SG9999003800.SGD","IE00BBT3K403.USD","BK4581","LU0321505439.SGD","LU0456855351.SGD","BK4585","SG9999013999.USD","LU0122379950.USD","IE000M9KFDE8.USD","PFE","LU0058720904.USD","LU0225284248.USD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2593474724","title":"辉瑞称一名参与血友病药物Hympavzi长期研究的患者死亡","url":"https://stock-news.laohu8.com/highlight/detail?id=2593474724","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593474724?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:50","pubTimestamp":1766541055,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4568","BK4592","IE00BBT3K403.USD","BK4550","SG9999002232.USD","LU0306806265.USD","IE00BLSP4239.USD","LU0985481810.HKD","LU0234572021.USD","SG9999003800.SGD","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999013999.USD","BK4599","LU0058720904.USD","SG9999001176.SGD","LU0868494617.USD","LU0321505439.SGD","LU1894683348.USD","LU1894683264.USD","IE00BLSP4452.SGD","LU1883839398.USD","SG9999002224.SGD","SG9999011175.SGD","LU1066053197.SGD","LU1023059063.AUD","BK4533","BK4581","LU1057294990.SGD","BK4534","LU0321505868.SGD","BK4588","LU0122379950.USD","BK4007","IE0002270589.USD","LU0306807586.USD","IE00B19Z3581.USD","LU0170899867.USD","IE000M9KFDE8.USD","PFE","LU0289739699.SGD","LU1066051498.USD","LU0456855351.SGD","LU0225284248.USD","SG9999001176.USD","BK4585","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"1161217813","title":"辉瑞：参与研究针对合并或不合并抑制剂的血友病A/B患者的Marstacimab长期延伸试验的参与者于12月去世","url":"https://stock-news.laohu8.com/highlight/detail?id=1161217813","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161217813?lang=zh_cn&edition=full","pubTime":"2025-12-24 00:05","pubTimestamp":1766505905,"startTime":"0","endTime":"0","summary":"辉瑞：参与研究针对合并或不合并抑制剂的血友病A/B患者的Marstacimab长期延伸试验的参与者于12月去世","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1066053197.SGD","LU0225771236.USD","BK4550","PFE","LU0225284248.USD","BK4592","SG9999013999.USD","BK4599","BK4534","LU0456855351.SGD","SG9999001176.SGD","LU1066051498.USD","LU0868494617.USD","IE00B19Z3B42.SGD","BK4007","IE00BLSP4239.USD","BK4588","BK4533","LU0122379950.USD","SG9999001176.USD","SG9999003800.SGD","LU0306806265.USD","SG9999002224.SGD","BK4568","SG9999002232.USD","LU0170899867.USD","IE00BLSP4452.SGD","IE0002270589.USD","LU0234572021.USD","LU0321505439.SGD","SG9999011175.SGD","IE00BBT3K403.USD","BK4585","LU0289739699.SGD","LU0058720904.USD","IE000M9KFDE8.USD","LU0985481810.HKD","LU1057294990.SGD","SGXZ57979304.SGD","LU0321505868.SGD","BK4581","LU1023059063.AUD","LU1894683264.USD","IE00B19Z3581.USD","LU1894683348.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"1132561000","title":"辉瑞：临床试验参与者的安全和福祉始终是我们的首要任务，我们致力于透明度","url":"https://stock-news.laohu8.com/highlight/detail?id=1132561000","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132561000?lang=zh_cn&edition=full","pubTime":"2025-12-23 23:56","pubTimestamp":1766505400,"startTime":"0","endTime":"0","summary":"辉瑞：临床试验参与者的安全和福祉始终是我们的首要任务，我们致力于透明度","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0234572021.USD","LU1057294990.SGD","IE0002270589.USD","LU0289739699.SGD","BK4007","LU0306807586.USD","BK4533","PFE","BK4534","IE000M9KFDE8.USD","LU1883839398.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU0321505868.SGD","LU1894683348.USD","BK4585","IE00B19Z3581.USD","LU1066053197.SGD","SG9999013999.USD","BK4588","LU0170899867.USD","SG9999001176.SGD","BK4592","LU0306806265.USD","LU1894683264.USD","SGXZ57979304.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","BK4581","BK4599","LU0058720904.USD","LU1023059063.AUD","BK4550","LU1066051498.USD","LU0985481810.HKD","SG9999011175.SGD","SG9999003800.SGD","SG9999001176.USD","IE00BBT3K403.USD","BK4568","LU0868494617.USD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","LU0225284248.USD","SG9999002232.USD"],"gpt_icon":0},{"id":"2593469996","title":"2025生物制药5大失败临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2593469996","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593469996?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:10","pubTimestamp":1766455833,"startTime":"0","endTime":"0","summary":"Biospace近日总结了生物制药领域在2025年五项代价高昂的临床失败，并分析了其引发的连锁反应。Alector与GSK于2021年7月达成合作，GSK投入预付款7亿美元，并承诺最高15亿美元的里程碑付款，以合作研发两款神经领域药物。双方2021年协议中的第二款药物nivisnebart目前处于II期研发阶段，用于治疗早期阿尔茨海默病。▌诺和诺德GLP-1药物阿尔茨海默适应症临床试验失利在神经科学领域折戟的还有诺和诺德。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223102629a46cc8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223102629a46cc8bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0058720904.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","ALEC","BK4213","BK4534","LU0321505439.SGD","BK4533","IE00BKVL7J92.USD","GSK.UK","IE00BBT3K403.USD","LU0306806265.USD","LU0456855351.SGD","LU1894683348.USD","IE00BLSP4452.SGD","SG9999011175.SGD","LU0868494617.USD","LU0234572021.USD","LU1894683264.USD","LU1066053197.SGD","SG9999013999.USD","LU0321505868.SGD","BK4139","LU1066051498.USD","BK4581","LU0306807586.USD","GSK","LU1829250122.USD","BK4532","LU0289739699.SGD","LU1023059063.AUD","LU1883839398.USD","LU0985481810.HKD","SG9999001176.SGD","IE000M9KFDE8.USD","SG9999003800.SGD","LU1093756325.SGD","BK4592","SG9999001176.USD","SGXZ57979304.SGD","LU1093756168.USD","SG9999002224.SGD","LU0170899867.USD","BK4550","LU0122379950.USD","IE00BZ1G4Q59.USD","BK4007","IE0002270589.USD","BK4568","LU0154236417.USD","LU1057294990.SGD","BMY","BK4585","LU0225771236.USD","NVO","BK4588","LU0225284248.USD","SG9999002232.USD","PFE","IE00B19Z3581.USD","BK4599"],"gpt_icon":1},{"id":"1144867840","title":"Flagship Pioneering与Repertoire®免疫药物公司宣布与辉瑞达成战略合作，旨在寻找针对前列腺癌的T细胞靶向免疫药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1144867840","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144867840?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:09","pubTimestamp":1766408964,"startTime":"0","endTime":"0","summary":"Flagship Pioneering与Repertoire®免疫药物公司宣布与辉瑞达成战略合作，旨在寻找针对前列腺癌的T细胞靶向免疫药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0868494617.USD","LU0456855351.SGD","LU1894683264.USD","BK4533","LU0321505868.SGD","PFE","SG9999001176.USD","IE00BLSP4452.SGD","LU1023059063.AUD","SG9999002224.SGD","SG9999013999.USD","BK4588","BK4568","LU1894683348.USD","LU1883839398.USD","IE0002270589.USD","IE00BBT3K403.USD","LU0225771236.USD","LU0321505439.SGD","BK4592","LU0289739699.SGD","BK4581","BK4599","SG9999011175.SGD","IE000M9KFDE8.USD","BK4534","LU0058720904.USD","SG9999002232.USD","SG9999001176.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4007","LU1066051498.USD","IE00BLSP4239.USD","LU0225284248.USD","LU1066053197.SGD","BK4585","LU0306807586.USD","LU0122379950.USD","LU0306806265.USD","SG9999003800.SGD","BK4550","LU0170899867.USD","IE00B19Z3581.USD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2592923143","title":"辉瑞报告其实验性药物针对特定医疗状况的临床试验结果积极Pfizer Reports Positive Clinical Trial Results for Experimental Drug Targeting Specific Medical Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2592923143","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592923143?lang=zh_cn&edition=full","pubTime":"2025-12-17 23:37","pubTimestamp":1765985820,"startTime":"0","endTime":"0","summary":"by GOAI由GOAI生成Share To分享到Pfizer has reported a significant development in its biotech endeavors, marking progress after facing challenges in recent years. The pharmaceutical company announced positive results from a clinical trial for one of its experimental drugs, which targets a specific medical condition. This outcome represents an important milestone for Pfizer as it continues to navigate the competitive landscape of drug development..辉瑞公司在其生物技术领域报告了一项重要进展，标志着近年来面临挑战后取得了进步。这一成果代表了辉瑞在继续应对药物开发竞争环境中的一个重要里程碑。辉瑞的最新成就为生物技术和医药突破的未来讨论增添了新的内容。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217233913a4579211&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217233913a4579211&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4533","LU1894683264.USD","LU0868494617.USD","SG9999002224.SGD","IE00BLSP4452.SGD","BK4588","BK4534","IE0002270589.USD","IE00BLSP4239.USD","LU1023059063.AUD","IE00B19Z3581.USD","LU0289739699.SGD","LU0234572021.USD","SG9999001176.USD","SG9999002232.USD","LU0985481810.HKD","LU0306807586.USD","IE00B19Z3B42.SGD","BK4568","BK4599","LU1066051498.USD","LU1894683348.USD","LU0170899867.USD","BK4550","LU0306806265.USD","BK4592","LU0321505868.SGD","LU1883839398.USD","SG9999011175.SGD","SGXZ57979304.SGD","SG9999001176.SGD","LU1066053197.SGD","LU0225771236.USD","SG9999003800.SGD","IE00BBT3K403.USD","BK4581","LU0321505439.SGD","LU0456855351.SGD","BK4585","SG9999013999.USD","LU0122379950.USD","IE000M9KFDE8.USD","PFE","LU0058720904.USD","LU0225284248.USD","LU1057294990.SGD"],"gpt_icon":1},{"id":"2592923455","title":"K+EV显著改善MIBC辅助治疗EFS和OS","url":"https://stock-news.laohu8.com/highlight/detail?id=2592923455","media":"华创新药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592923455?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:30","pubTimestamp":1765978212,"startTime":"0","endTime":"0","summary":"MIBC约占所有膀胱癌病例的30%。对于符合条件的MIBC患者，标准治疗是顺铂为基础的新辅助化疗，随后进行手术。然而，即使接受手术，仍有一半的MIBC患者会出现疾病复发。PADCEV联合pembrolizumab目前尚未获批用于适合顺铂治疗的MIBC患者的新辅助和辅助治疗。+++关于EV-304/ KEYNOTE-B15试验EV-304试验是一项正在进行的、开放标签、随机、对照的III期研究，旨在评估PADCEV联合pembrolizumab作为新辅助及辅助治疗对比新辅助化疗用于适合顺铂化疗的MIBC患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217221245a6ae610e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217221245a6ae610e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0170899867.USD","LU1057294990.SGD","BK4599","LU1066053197.SGD","SG9999003800.SGD","LU1894683348.USD","SG9999001176.USD","LU0321505439.SGD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU0868494617.USD","LU0985481810.HKD","LU0321505868.SGD","BK4534","BK4533","LU0456855351.SGD","BK4592","IE00BLSP4452.SGD","LU0225771236.USD","BK4585","BK4550","BK4588","PFE","SG9999002232.USD","LU1023059063.AUD","LU0306807586.USD","SGXZ57979304.SGD","LU0058720904.USD","LU0306806265.USD","BK4007","LU0289739699.SGD","SG9999001176.SGD","SG9999011175.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","LU0225284248.USD","BK4568","LU0122379950.USD","SG9999013999.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU0234572021.USD","LU1066051498.USD","LU1894683264.USD","IE0002270589.USD","IE00B19Z3581.USD","BK4581"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.pfizer.com","stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0271},{"period":"3month","weight":0.0312},{"period":"6month","weight":0.0232},{"period":"1year","weight":-0.0616},{"period":"ytd","weight":0.01}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.456522,"avgChangeRate":0.001415},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.007083},{"month":3,"riseRate":0.6,"avgChangeRate":0.014714},{"month":4,"riseRate":0.586957,"avgChangeRate":0.018253},{"month":5,"riseRate":0.5,"avgChangeRate":0.007748},{"month":6,"riseRate":0.5,"avgChangeRate":0.002798},{"month":7,"riseRate":0.478261,"avgChangeRate":0.011357},{"month":8,"riseRate":0.456522,"avgChangeRate":0.0002},{"month":9,"riseRate":0.456522,"avgChangeRate":0.004432},{"month":10,"riseRate":0.630435,"avgChangeRate":0.013042},{"month":11,"riseRate":0.695652,"avgChangeRate":0.028255},{"month":12,"riseRate":0.5,"avgChangeRate":0.008452}],"exchange":"NYSE","name":"辉瑞","nameEN":"Pfizer"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辉瑞,PFE,辉瑞股票,辉瑞股票老虎,辉瑞股票老虎国际,辉瑞行情,辉瑞股票行情,辉瑞股价,辉瑞股市,辉瑞股票价格,辉瑞股票交易,辉瑞股票购买,辉瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}